» Authors » Lisa E Vaughan

Lisa E Vaughan

Explore the profile of Lisa E Vaughan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 786
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Charkviani M, Brochero M, Mohan A, Vaughan L, Sandahl T, De Menezes Silva Corrae A, et al.
Nephrol Dial Transplant . 2025 Jan; PMID: 39805729
Background And Hypothesis: Teclistamab, a novel bispecific monoclonal antibody targeting CD3 and B-cell maturation antigen (BCMA), and chimeric antigen receptor T-cell (CAR-T) therapy are promising options for treating relapsed/refractory multiple...
2.
Chamberlain A, Alonso A, Noseworthy P, Siontis K, Gersh B, Killian J, et al.
J Multimorb Comorb . 2024 Dec; 14:26335565241310281. PMID: 39712398
Background: Multimorbidity is common in patients with atrial fibrillation (AF), yet comorbidity patterns are not well documented. Methods: The prevalence of 18 chronic conditions (6 cardiometabolic, 7 other somatic, 5...
3.
Vaughan L, Kanaji Y, Suvakov S, Parashuram S, Butler Tobah Y, Chamberlain A, et al.
J Am Coll Cardiol . 2024 Nov; 84(23):2264-2274. PMID: 39503653
Background: Angiographic evidence of the anatomy of coronary arteries and the type of coronary artery lesions in women with a history of hypertensive disorders of pregnancy (HDP) are poorly documented....
4.
Suvakov S, Vaughan L, Parashuram S, Butler Tobah Y, Jayachandran M, Kattah A, et al.
Hypertension . 2024 May; 81(7):1550-1560. PMID: 38690656
Background: Senescence, a mechanism of cellular aging, which is characterized by irreversible proliferation arrest and a proinflammatory secretory phenotype, has been documented in women with preeclampsia. As cellular senescence can...
5.
Sandoval L, Radhakrishnan Y, Vaughan L, Potter A, Mansfield A, Herrmann S
Kidney Int Rep . 2023 Nov; 8(11):2482-2485. PMID: 38025245
No abstract available.
6.
Sy-Go J, Moubarak S, Vaughan L, Klomjit N, Viehman J, Fervenza F, et al.
Clin J Am Soc Nephrol . 2023 Nov; 19(3):319-328. PMID: 37948069
Background: Little is known about the prognostic significance of monoclonal gammopathy of undetermined and renal significance (MGUS and MGRS) in patients with CKD. The objective of this study was to...
7.
Dines V, Kattah A, Weaver A, Vaughan L, Chamberlain A, Bielinski S, et al.
Hypertension . 2023 Jul; 80(9):1940-1948. PMID: 37489531
Background: Hypertensive disorders of pregnancy (HDP) have been associated with an increased risk of chronic hypertension for both mothers and offspring. We sought to quantify the incidence of chronic hypertension...
8.
Thongprayoon C, Vaughan L, Barreto E, Mehta R, Koo K, Schulte P, et al.
J Am Soc Nephrol . 2023 May; 34(8):1399-1408. PMID: 37184480
Significance Statement: Antibiotics modify human microbiomes and may contribute to kidney stone risk. In a population-based case-control study using 1247 chart-validated first-time symptomatic kidney stone formers and 4024 age- and...
9.
Vaughan L, Lieske J, Milliner D, Schulte P
J Clin Transl Sci . 2023 Feb; 7(1):e8. PMID: 36755528
Background: Time-dependent Cox proportional hazards regression is a popular statistical method used in kidney disease research to evaluate associations between biomarkers collected serially over time with progression to kidney failure....
10.
Thongprayoon C, Vuckovic I, Vaughan L, Macura S, Larson N, DCosta M, et al.
J Am Soc Nephrol . 2022 Oct; 33(11):2071-2086. PMID: 36316097
Background: The urine metabolites and chemistries that contribute to kidney stone formation are not fully understood. This study examined differences between the urine metabolic and chemistries profiles of first-time stone...